
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | 2026-05-11 | Kamke Trent G | Senior V. P., Operations | Sale | 2,928 | $107.00 | $313K | 3,749 | View ↗ | |
| 2026-05-08 | 2026-05-11 | LeMaitre George W | Director & Chairman and CEO | Sale | 27.9K | $108.69 | $3.03M | 1.43M | View ↗ | |
| 2026-05-07 | 2026-05-11 | Ross Bridget A | Director | Sale | 5,044 | $111.10 | $560K | 3,942 | View ↗ | |
| 2026-05-07 | 2026-05-11 | Jasinski Lawrence J | Director | Sale | 3,943 | $110.00 | $434K | 4,714 | View ↗ | |
| 2026-05-07 | 2026-05-11 | LeMaitre George W | Director & Chairman and CEO | Sale | 18.6K | $107.64 | $2.00M | 1.46M | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $249.6M+13.5% | $219.9M+13.6% | $193.5M+19.7% | $161.7M+4.7% | $154.4M |
| Cost of sales | $71.1M+3.0% | $69.0M+3.8% | $66.4M+17.1% | $56.8M+7.0% | $53.0M |
| Gross profit | $178.5M+18.3% | $150.9M+18.8% | $127.0M+21.1% | $104.9M+3.5% | $101.4M |
| Sales and marketing | $54.5M+16.5% | $46.7M+13.8% | $41.1M+24.7% | $32.9M+19.0% | $27.7M |
| General and administrative | $42.0M+15.9% | $36.3M+13.9% | $31.8M+10.7% | $28.7M+12.7% | $25.5M |
| Research and development | $14.1M-9.7% | $15.7M-7.8% | $17.0M+27.6% | $13.3M+12.7% | $11.8M |
| Restructuring | $0 | $0-100.0% | $485K-84.4% | $3.1M | $0 |
| Total operating expenses | $110.6M+12.1% | $98.6M+9.2% | $90.3M+15.7% | $78.1M+20.2% | $65.0M |
| Income from operations | $67.9M+30.0% | $52.3M+42.3% | $36.7M+36.8% | $26.8M-26.3% | $36.4M |
| Other income (expense): | — | — | — | — | $197K |
| Investment income | $13.1M+164.6% | $4.9M+60.8% | $3.1M+212.1% | $986K+400.5% | $197K |
| Interest expense | -$5.2M-2428.8% | -$205K | — | $0-100.0% | $2.2M |
| Other income (loss), net | -$638K-410.4% | -$125K+60.2% | -$314K+3.4% | -$325K-180.2% | -$116K |
| Income before income taxes | $75.2M+32.2% | $56.9M+44.1% | $39.5M+43.6% | $27.5M-19.8% | $34.3M |
| Provision for income taxes | $17.4M+35.9% | $12.8M+37.0% | $9.4M+36.7% | $6.9M-7.1% | $7.4M |
| Net income | $57.7M+31.1% | $44.0M+46.3% | $30.1M+45.9% | $20.6M-23.3% | $26.9M |
| Basic (in dollars per share) | $3K+30.1% | $2K+44.1% | $1K+44.7% | $940-26.0% | $1K |
| Diluted (in dollars per share) | $3K+30.6% | $2K+44.0% | $1K+44.1% | $930-25.6% | $1K |
| Basic (in shares) | $22.6M+0.8% | $22.5M+1.1% | $22.2M+1.1% | $22.0M+3.9% | $21.2M |
| Diluted (in shares) | $22.9M+0.7% | $22.8M+1.6% | $22.4M+1.1% | $22.2M+3.2% | $21.5M |
| Cash dividends declared per common share (in dollars per share) | $800+25.0% | $640+14.3% | $560+12.0% | $500+13.6% | $440 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
1 Reason to Avoid LMAT and 1 Stock to Buy Instead
Portfolio Update - April Dividend Income Report